Related Experiment Video
Updated: Jul 5, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet function in intravascular device implant-induced intimal injury
1Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD 20993-0002, USA. belay.tesfamariam@fda.hhs.gov <belay.tesfamariam@fda.hhs.gov>
Summary
Platelet activation initiates arterial thrombus formation after intimal injury from devices. Understanding these platelet pathways is key for developing antiplatelet therapies to prevent thrombosis.
Area of Science:
- Cardiovascular Biology
- Hemostasis and Thrombosis
- Biomedical Engineering
Background:
- Platelets rapidly respond to intimal injury by adhering to exposed subendothelial matrix, leading to arterial thrombus formation.
- Platelet activation involves complex receptor-mediated signaling, mediator release, and recruitment of additional platelets.
- A healthy endothelium maintains blood fluidity by regulating vessel tone and synthesizing platelet inhibitors/activators.
Purpose of the Study:
- To review the temporal events following intravascular device implantation.
- To elucidate the mechanisms of platelet activation and thrombus formation.
- To identify potential therapeutic targets for antiplatelet therapy.
Main Methods:
- Review of scientific literature on platelet function and intravascular devices.
- Analysis of platelet activation pathways and signaling events.
- Summary of temporal sequence from endothelial injury to thrombus formation.
Main Results:
- Intravascular device implantation causes intimal injury, endothelial dysfunction, and prothrombotic conditions.
- Platelet adhesion, aggregation, and thrombus formation are triggered by exposed subendothelial matrix.
- Redundant platelet activation pathways present multiple targets for therapeutic intervention.
Conclusions:
- Understanding platelet regulatory mechanisms is crucial for preventing thrombosis after percutaneous coronary intervention.
- Targeting specific platelet pathways offers a strategy for developing effective antiplatelet therapies.
- Comprehensive knowledge of platelet responses to intimal injury informs future treatment strategies.
More Related Videos
05:43An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
Published on: November 8, 2024
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...